When you breathe in you inspire, when you don't breathe, you ... expire: New insights regarding opioid-induced ventilatory depression

Anesthesiology

Volumn 99, Issue 4, 2003, Pages 767-770

  Gross, Jeffrey B ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE 6 GLUCURONIDE; MORPHINE SULFATE; OPIATE; REMIFENTANIL;

ANESTHESIA; BREATHING PATTERN; BREATHING RATE; EDITORIAL; HYPERCAPNIA; INSPIRATORY CAPACITY; LUNG VENTILATION; PRIORITY JOURNAL; RESPIRATION DEPRESSION;

ANALGESICS, OPIOID; EXPIRATORY RESERVE VOLUME; HUMANS; INSPIRATORY CAPACITY; PULMONARY VENTILATION; RESPIRATION;

EID: 0141767113     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200310000-00002     Document Type: Editorial

References (11)

1. Bouillon T, Bruhn J, Radu-Radulescu L, Andresen C, Cohane C, Shafer SL: A model of the ventilatory depressant potency of remifentanil in the non-steady state. ANESTHESIOLOGY 2003; 99:779-87
2. Romberg R, Olofsen E, Sarton E, Teppema L, Dahan A: The pharmacodynamic effect of morphine-6-glucuronide versus morphine on hypoxic and hypercapnic breathing in healthy volunteers. ANESTHESIOLOGY 2003; 99:788-98
3. Lötsch J, Geisslinger G: Morphine-6-glucuronide: An analgesic of the future? Clin Pharmacokinet 2001; 40:485-99
4. Gross JB: Resting ventilation measurements may be misleading (Letter). ANESTHESIOLOGY 1984; 61:110
5. Babenco HD, Conard PF, Gross JB: The pharmacodynamic effect of a remifentanil bolus on ventilatory control. ANESTHESIOLOGY 2000; 92:393-8
6. Glass PS, Iselin-Chaves LA, Goodman D, Delong E, Hermann DJ: Determination of the potency of remifentanil compared with alfentanil using ventilatory depression as the measure of opioid effect. ANESTHESIOLOGY 1999; 90:1556-63
7. Person RT, Simon PJ, Bakhshi K, Clark SJ, Langford RM, Slevin ML: Randomized placebo-controlled trial of the activity of the morphine glucuronides. Clin Pharmacol Ther 2000; 68:667-76
8. Lötsch J, Kobal G, Stockmann A, Brune K, Geisslinger G: Lack of analgesic activity of morphine-6-glucuronide after short-term intravenous administration in healthy volunteers. ANESTHESIOLOGY 1997; 87:1348-58
9. Bickel U, Schumacher OP, Kang YS, Voigt K: Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat. J Pharmacol Exp Ther 1996; 278:107-13
10. Lötsch J, Skarke C, Schmidt H, Grösch S, Geisslinger G: The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers. ANESTHESIOLOGY 2001; 95:1329-38
11. Grace D, Fee JPH: A comparison of intrathecal morphine-6-glucuronide and intrathecal morphine sulfate as analgesics for total hip replacement. Anesth Analg 1996; 83:1055-9